Profile | GDS4284 / 213813_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 713.464 | 69 |
GSM687648 | Patient 402 control | 708.629 | 69 |
GSM687653 | Patient 403 control | 582.859 | 67 |
GSM687658 | Patient 404 control | 655.651 | 68 |
GSM687663 | Patient 411 control | 713.33 | 69 |
GSM687668 | Patient 422 control | 561.67 | 65 |
GSM687673 | Patient 424 control | 867.821 | 72 |
GSM687678 | Patient 425 control | 747.169 | 69 |
GSM687683 | Patient 427 control | 826.854 | 70 |
GSM687688 | Patient 428 control | 520.593 | 64 |
GSM687695 | Patient 441 control | 3620.16 | 91 |
GSM687699 | Patient 443 control | 1529.61 | 80 |
GSM687704 | Patient 444 control | 619.696 | 67 |
GSM687707 | Patient 448 control | 1338.05 | 79 |
GSM687712 | Patient 449 control | 561.654 | 65 |
GSM687719 | Patient 450 control | 851.389 | 71 |
GSM687724 | Patient 451 control | 1639.93 | 82 |
GSM687728 | Patient 452 control | 1164.33 | 77 |
GSM687646 | Patient 401 treated 24h | 422.811 | 60 |
GSM687649 | Patient 402 treated 24h | 617.907 | 67 |
GSM687665 | Patient 411 treated 24h | 821.073 | 71 |
GSM687651 | Patient 402 treated 4 weeks | 629.91 | 66 |
GSM687667 | Patient 411 treated 4 weeks | 558.513 | 65 |
GSM687670 | Patient 422 treated 24h | 367.675 | 58 |
GSM687671 | Patient 422 treated 4 weeks | 542.672 | 65 |
GSM687654 | Patient 403 treated 24h | 657.303 | 68 |
GSM687675 | Patient 424 treated 24h | 782.229 | 70 |
GSM687685 | Patient 427 treated 24h | 633.706 | 67 |
GSM687656 | Patient 403 treated 4 weeks | 398.043 | 61 |
GSM687677 | Patient 424 treated 4 weeks | 612.984 | 66 |
GSM687687 | Patient 427 treated 4 weeks | 396.409 | 60 |
GSM687692 | Patient 428 treated 4h | 652.166 | 67 |
GSM687716 | Patient 449 treated 4h | 444.256 | 62 |
GSM687722 | Patient 450 treated 4h | 789.231 | 70 |
GSM687680 | Patient 425 treated 24h | 637.802 | 67 |
GSM687690 | Patient 428 treated 24h | 1019.98 | 75 |
GSM687700 | Patient 443 treated 24h | 1347.16 | 78 |
GSM687705 | Patient 444 treated 24h | 843.048 | 72 |
GSM687714 | Patient 449 treated 24h | 544.053 | 65 |
GSM687721 | Patient 450 treated 24h | 700.359 | 68 |
GSM687682 | Patient 425 treated 4 weeks | 813.718 | 71 |
GSM687694 | Patient 428 treated 4 weeks | 342.176 | 58 |
GSM687702 | Patient 443 treated 4 weeks | 803.538 | 70 |
GSM687718 | Patient 449 treated 4 weeks | 690.261 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 539.823 | 64 |
GSM687661 | Patient 404 treated 4h | 684.715 | 68 |
GSM687710 | Patient 448 treated 4h | 1325.98 | 79 |
GSM687726 | Patient 451 treated 4h | 1298.67 | 78 |
GSM687730 | Patient 452 treated 4h | 13711.5 | 98 |
GSM687660 | Patient 404 treated 24h | 1570.76 | 82 |
GSM687697 | Patient 441 treated 24h | 2429.1 | 87 |
GSM687709 | Patient 448 treated 24h | 747.042 | 70 |
GSM687725 | Patient 451 treated 24h | 1558.13 | 81 |
GSM687729 | Patient 452 treated 24h | 2890.5 | 89 |
GSM687727 | Patient 451 treated 4 weeks | 1424.34 | 79 |
GSM687731 | Patient 452 treated 4 weeks | 1270.69 | 77 |